Solesence, Inc. (SLSN)
| Market Cap | 67.11M -73.5% |
| Revenue (ttm) | 55.37M -14.0% |
| Net Income | -2.91M |
| EPS | -0.05 |
| Shares Out | 70.65M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 5,048 |
| Open | 0.9549 |
| Previous Close | 0.9549 |
| Day's Range | 0.9500 - 0.9850 |
| 52-Week Range | 0.6133 - 4.5500 |
| Beta | 1.26 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 19, 2026 |
About SLSN
Solesence, Inc., a science-driven company, provides engineered materials, formulation development, and commercial manufacturing services in the United States. The company engages in the manufacture and supply of surface engineered zinc oxide and titanium dioxide ingredients. It also provides skin care formulations with mineral-based UV protection enabled by proprietary active pharmaceutical ingredients; and skin health products, such as sunscreens and daily care products. The company sells products in various markets, including medical diagnost... [Read more]
Financial Performance
In 2025, Solesence's revenue was $62.06 million, an increase of 18.56% compared to the previous year's $52.35 million. Earnings were $1.79 million, a decrease of -57.73%.
Financial StatementsNews
Solesence reports Q2 revenue $15.3M vs $20.4M last year
“In the second quarter, our business focused on operational execution and financial discipline as we continue implementing our Transform and Transcend strategy,” said Kevin Cureton, President and Chie...
Solésence Reports Second Quarter 2026 Financial Results
Please call Alissa Nakamoto at 216-509-9062 to confirm the details of the release. Please ensure that the release has the same distributions as past PRs.
Solesence Earnings Call Transcript: Q2 2026
Q2 2026 saw revenue decline year-over-year due to prior product launch timing, but operational efficiency improved, and gross margin held steady. Full-year revenue is projected to surpass 2025, with strong order momentum and new product launches in high-growth segments.
Solesence Quarterly report: Q2 2026
Solesence has published its Q2 2026 quarterly earnings report on August 19, 2026.
Solesence Earnings release: Q2 2026
Solesence released its Q2 2026 earnings on August 19, 2026, summarizing the period's financial results.
Solesence Slides: Q2 2026
Solesence has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 19, 2026.
Solésence To Report Second Quarter 2026 Financial Results and Host a Conference Call on August 11
ROMEOVILLE, Ill., July 28, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced t...
Solésence Brings Patent-Backed Skin Health Innovation to Hair and Scalp
New White Label Collection, Powered by WHSPR™ and Kleair™, Debuts with Revitalizing Scalp Serum and Scalp Screen Dry Shampoo SPF 45+ Sunscreen
Solésence Named Contract Manufacturing Partner of the Year in the 2026 Cosmetics Business Innovation Awards
Global Award Recognizes Excellence in Service, Reliability, and Innovation ROMEOVILLE, Ill., June 18, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc.
Solésence Day Mode Hero Concealer SPF 50+ Wins Three Categories at the 2026 Cosmetics & Toiletries Allē Awards, Marking Fourth Year of Recognition
SPF-Infused Concealer Featuring Kleair™, WHSPR™, and Chromalüm™ Recognized Across Anti-Aging, Color Cosmetics, and Compromised Skin
Solésence Supports Landmark Report on UV Safety in the United Kingdom as Member of UV Safety Coalition
The report, led by the United Kingdom's APPG for Beauty, Hair & Wellbeing, calls for a national strategy to combat UV exposure, including Government support to enable access to adequate protection, bu...
Solesence Earnings Call Transcript: Q1 2026
Revenue declined year-over-year due to shipment delays, but gross margin improved and a healthy $47M order pipeline supports a positive outlook. Strategic investments and new technology launches position the company for margin expansion and long-term growth.
Solesence Earnings release: Q1 2026
Solesence released its Q1 2026 earnings on May 12, 2026, summarizing the period's financial results.
Solesence Quarterly report: Q1 2026
Solesence has published its Q1 2026 quarterly earnings report on May 12, 2026.
Solesence Slides: Q1 2026
Solesence has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 12, 2026.
Solésence Reports First Quarter 2026 Financial Results
Advances implementation of Transform and Transcend strategic initiative across Operational Excellence and New Technology Commercialization ROMEOVILLE, Ill., May 12, 2026 (GLOBE NEWSWIRE) -- Solésence,...
Solésence Launches New Skin Health Technologies: WHSPR™ and Chromalüm™
New platform technologies enable OTC-grade sensitive skin claims in previously inaccessible anhydrous formats and bring environmental protection deeper into the color cosmetics assortment
Solésence To Report First Quarter 2026 Financial Results and Host a Conference Call on May 12
ROMEOVILLE, Ill., April 28, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced ...
Solésence, Inc. Announces Appointment of New Independent Director
Marc James to Join Board of Directors and Serve on Audit, Compensation, and Nominating Committees ROMEOVILLE, Ill., April 27, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scien...
Solesence Earnings Call Transcript: Q4 2025
Revenue hit a record $62.1M in 2025, up 18.6% year-over-year, but margin compression limited profit growth. Operational improvements and the Transform and Transcend initiative aim to boost margins and EBITDA in 2026, with a 30% gross margin floor set.
Solesence Annual report: Q4 2025
Solesence has published its Q4 2025 annual report on March 31, 2026.
Solesence Earnings release: Q4 2025
Solesence released its Q4 2025 earnings on March 31, 2026, summarizing the period's financial results.
Solésence Reports Fourth Quarter and Full-Year 2025 Financial Results
Full Year 2025 record revenue of $62.1 million ROMEOVILLE, Ill., March 31, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beaut...
Solésence To Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call on March 31, 2026
ROMEOVILLE, Ill., March 19, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced ...
Solesence appoints Yoolie Park as VP, brand partnerships
Solesence has appointed Yoolie Park as Vice President of Brand Partnerships. In this role, Park will lead strategic relationships with emerging and established beauty brands, expanding Solesence’s abi...